ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

133
Analysis
Health CareJapan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
bullishMSCI ACWI Index
17 Aug 2018 23:22

Global Strategy: Carnage Continuation Amid Turkey Turmoil and US Dollar Breakout

Corrections across global ex-US markets continue to limit attractive investment opportunities from both a price and relative strength perspective. ...

Logo
495 Views
Share
29 Jul 2018 18:01

Japan Fortnightly Update: Banks to Neutral/Utilities to Negative - Results Momentum Still Slowing

CYCLICAL SECTORS RALLY WITH THE MARKET - Japanese equities have rallied 3.6% over the last two weeks, and the market composite is now flat since...

Logo
379 Views
Share
24 Jul 2018 04:25

Global Equity Strategy: Where to Hide Outside the U.S.

The U.S. has continued to separate itself from broad emerging market and developed international indexes. One positive is that MSCI EM and MSCI...

Logo
499 Views
Share
bearishFast Retailing
23 Jul 2018 07:38

JAPAN PASSIVE:  The Nikkei 225 Baskets if BOJ Changes

Last week in JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225 I discussed the BOJ's past and current ETF purchasing selection, ownership,...

Logo
573 Views
Share
bearishFast Retailing
19 Jul 2018 02:00

JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225

The last couple of weeks have seen stories carried in the media about the impact of the BOJ in its equity index ETF buying program. Some of these...

Logo
1.6k Views
Share
x